Katherine M. A. Kline
Known title: DirectorCIK: 0001753616
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BILL Draws Investor Interest Among Texas & Florida Software Plays. Investors are monitoring BILL as part of a group of Texas and Florida software companies gaining attention. The stock sits near a 50‑level RSI and has recently touched its 200‑day moving average, while a support level at $47.26 has been tested multiple times. Analysts have a wide target range, and the company’s valuation is high relative to earnings. These factors may influence trading activity in the coming days.
Transaction History
| HBAN | ▲ Buy | Grant | 1,026 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 53 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 854 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 43 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 9,320 | $0 | 5/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 48 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 874 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 787 | $0 | 1/2/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 44 | $0 | 1/2/2026 | View on chart |
| BILL | ▲ Buy | Option Exercise | 2,095 | — | 12/5/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 800 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 44 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 45 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 786 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 9,404 | $0 | 5/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 798 | $0 | 4/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 50 | $0 | 4/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 45 | $0 | 1/2/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 728 | $0 | 1/2/2025 | View on chart |
| BILL | ▲ Buy | Option Exercise | 2,883 | — | 12/5/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 201 | $0 | 10/22/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 816 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 49 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 192 | $3K | 7/23/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 878 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 50 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 10,073 | $0 | 5/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 212 | $3K | 4/23/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 112 | $1K | 1/23/2024 | View on chart |
| BILL | ▲ Buy | Option Exercise | 1,733 | — | 12/7/2023 | View on chart |
| BILL | ▲ Buy | Option Exercise | 1,148 | — | 11/28/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 151 | $1K | 10/24/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 126 | $2K | 7/25/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 12,511 | $0 | 5/1/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 129 | $1K | 4/25/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 97 | $1K | 1/24/2023 | View on chart |
| BILL | ▲ Buy | Option Exercise | 873 | — | 12/8/2022 | View on chart |
| BILL | ▲ Buy | Option Exercise | 1,147 | — | 11/28/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 97 | $1K | 10/25/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 111 | $1K | 7/26/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 10,456 | $0 | 5/1/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 105 | $1K | 4/25/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 92 | $1K | 1/26/2022 | View on chart |
| BILL | ▲ Buy | Option Exercise | 1,148 | — | 11/28/2021 | View on chart |
| HBAN | ▲ Buy | Grant | 90 | $1K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted
Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.